NQO1 and colorectal cancer: Sulindac has been shown to be a potent chemo-protective agent against colorectal cancer in both human and animal models [25], while sulindac sulfide [18] and sulindac and its two metabolites [18], [28]] have been reported to upregulate the expression of carcinogen detoxification enzymes, including NQO1.